Acidity-activatable dynamic nanoparticles boost cancer immunotherapy

cell
Credit: CC0 Public Domain

Immunotherapy has great potential in clinical cancer treatment due to systematic activation of antitumor immunity. However, low immunogenicity, or negative feedback on immunotherapy, greatly hinders the efficacy of currently used cancer immunotherapy.

In a study published in Advanced Materials, a research team led by Yu Haijun from Shanghai Institute of Materia Medica of the Chinese Academy of Sciences proposed acidity-activatable dynamic nanoparticles to boost ferroptosis and immunogenic death (ICD) of for cancer .

Ferroptosis is a new type of cell death caused by (lip-ROS). The repairment axis of lip-ROS contains glutamate–cystine antiporter for synthesis of intracellular glutathione (System XC-) and Glutathione Peroxidase 4 (GPX4), both of which play important roles to fight against lip-ROS. Those produced lip-ROS were reported to act as "find-me" signals to promote the phagocytosis of antigen-presenting cells and to further activate cytotoxic T lymphocytes to enhance tumor immunotherapy.

The researchers firstly synthesized amphiphilic acid-sensitive block copolymer coupled with photosensitizer (pyrochloric acid, PPA) and phenylboric acid through hydrophobic interaction and π-π conjugation to encapsulate insoluble GPX4 inhibitor (RSL-3).

Then they found nanoparticles with external light can induce obvious ICD as well as cytotoxic T lymphocytes which secrete IFN-γ. IFN-γ and RSL-3 presented synergistically inhibition on the repairment axis and SystemXC—GPX4, while increased the accumulation of lipid-ROS in tumor cells, thus revealing the interaction between ferroptosis and immunotherapy.

Additionally, the researchers found that the nanoparticles combined with immune checkpoint therapy (ICB) dramatically reduced the tumor-infiltration of dedifferentiated tumor cells in a manner of ferroptosis.

The study offered a new way to improve ferroptosis-mediated tumor immunotherapy.

More information: Rundi Song et al, Acidity‐Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer, Advanced Materials (2021). DOI: 10.1002/adma.202101155

Journal information: Advanced Materials

Citation: Acidity-activatable dynamic nanoparticles boost cancer immunotherapy (2021, July 16) retrieved 2 February 2023 from https://phys.org/news/2021-07-acidity-activatable-dynamic-nanoparticles-boost-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Mitochondrial enzyme found to block cell death pathway points to new cancer treatment strategy

4 shares

Feedback to editors